The role of intestinal flora in improving bronchopulmonary dysplasia in preterm infants with breast milk

To explore the role of intestinal flora in improving bronchopulmonary dysplasia in premature infants from the perspective of lung and large intestine

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046584

Enrollment

Unknown

Registered

2021-05-22

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia

Interventions

Breastfeeding Group:Nil

Formula feeding group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gestational aged < 32 weeks.

Exclusion criteria

Exclusion criteria: 1. Combined with severe cardiovascular malformations, diaphragmatic hernia combined with pulmonary dysplasia, etc.; 2. There are inherited metabolic diseases, chromosomal abnormalities, etc.; 3. During the hospitalization period, those who gave up treatment due to various reasons and transferred to other hospitals for treatment.

Design outcomes

Primary

Measure	Time frame
Incidence of bronchopulmonary dysplasia;Differences in intestinal flora;	—

Countries

China

Contacts

Public ContactLi Run

The Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

lirun2008@163.com+86 13551668989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026